National Variation in Implementation of Sentinel Lymph Node Biopsy for Clinically Node-Positive Patients Undergoing Neoadjuvant Therapy
There has been de-escalation of axillary surgery with fewer patients undergoing ALND; however, overall there has been no significant change in the rates of obtaining three or more lymph nodes during SLNB following neoadjuvant chemotherapy, with significant facility-level variation observed.
Authors
- Brandy Sinco
- Lesly A. Dossett (ORCID: https://orcid.org/0000-0001-8060-1073)
- Ton Wang (ORCID: https://orcid.org/0000-0003-0437-3771)
- Tasha M. Hughes (ORCID: https://orcid.org/0000-0002-4678-1143)
- Melissa Pilewskie (ORCID: https://orcid.org/0000-0003-0508-6424)
- Crystal D. Taylor
Institutions
- Duke University (US)
- University of Michigan (US)
- Michigan Medicine (US)
- VA Center for Clinical Management Research (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1245/s10434-025-17293-x
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute